Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03717961 Completed - Clinical trials for Raynaud Phenomenon Secondary to Systemic Sclerosis

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

BRASS
Start date: October 15, 2018
Phase: Phase 3
Study type: Interventional

This study aims to assess whether or not a single injection schedule of botulinum toxin A (BTX-A) in both hands improves Raynaud phenomenon (RP) secondary to systemic sclerosis (SSc) better than a placebo at 4, 12 and 24 weeks after the treatment. This study's hypothesis is that the number of RP attacks per week from baseline to 4 weeks after treatment is significantly lower in the group treated with BTX-A than in the control group treated by the placebo. Furthermore, BTX-A in both hands is expected to improve both symptomatic (attack frequency, digital ulcer healing) and functional (pain, hand function, quality of life) symptoms of RP secondary to SSc more than placebo.

NCT ID: NCT03717883 Completed - Renal Disease Clinical Trials

ADPKD Alterations in Hepatic Transporter Function

Start date: September 17, 2018
Phase:
Study type: Observational

This is a single center, comparative cohort study to investigate alterations in hepatic transporter function in subjects with autosomal dominant polycystic kidney disease (ADPKD) compared to healthy subjects and subjects with non-ADPKD renal disease. Eligible subjects will be 18-65 years of age and of any race/ethnicity and gender.

NCT ID: NCT03717597 Completed - Clinical trials for Subjective Cognitive Concerns (SCC)

Nonrandomized Evaluation of a Multidimensional Behavioral Intervention

BBLite
Start date: April 26, 2018
Phase: N/A
Study type: Interventional

This intervention is designed to promote enhanced use of compensation strategies including calendar and task list use, and organization systems, as well as increased engagement with brain health activities including physical exercise, cognitive activities, and stress reduction.

NCT ID: NCT03717571 Completed - Clinical trials for Rotator Cuff Tear or Rupture, Not Specified as Traumatic

Superior Glenohumeral Translation in Patients With Degenerative Rotator Cuff Tears

ROTCUFF
Start date: October 4, 2018
Phase:
Study type: Observational

Degenerative partial and complete rupture of the rotator cuff is a common injury among elder patients. However, the clinical manifestation varies largely with some patients having severe pain and limiting range of motion and others having no complaints. The basic functions of the rotator cuff are to facilitate shoulder motion and stabilization and centering of the glenohumeral joint. The objective of this study is to quantify the difference in superior glenohumeral translation in patients with degenerative rotator cuff tear compared to healthy control subjects and to determine the effect of isolated complete supraspinatus tear and combined complete supraspinatus and either partial infraspinatus or partial subscapularis tear.

NCT ID: NCT03717415 Completed - Clinical trials for Locally Advanced or Metastatic Solid Tumor

A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors

Start date: January 2, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open-label Phase 1b/2 multicenter study of rebastinib (DCC-2036) in combination with carboplatin designed to evaluate the safety, tolerability, and pharmacokinetics (PK) in patients with advanced or metastatic solid tumors.

NCT ID: NCT03717233 Completed - Diabetic Foot Ulcer Clinical Trials

Assistive ExoSkeletons to Enable Wearable Rehabilitation Robotics

Start date: October 18, 2018
Phase: N/A
Study type: Interventional

Study will evaluate the use of lower-limb assistive exo-skeletons worn on the ankle and foot. Participants will wear the exo-skeletons and walk in a safe environment. Measurements will be taken to determine how the exo-skeletons affect the pressure on the feet of people with diabetic foot ulcer and how they walk.

NCT ID: NCT03717168 Completed - Clinical trials for Mechanical Ventilation Complication

Effects of Growth Hormone on Difficult Ventilator Weaning Patients

Start date: March 1, 2018
Phase: Phase 2
Study type: Interventional

Major abdominal surgeries may be followed by postoperative pulmonary complications (PPCs). These complications are common and can cause significant morbidity and mortality. Major operations are followed by acute respiratory insufficiency (RI) in 3%-27.4%, which causes prolonged hospital stay, high patient costs, high mortality rate and lower survival rates. The most crucial pulmonary postoperative complication is the prolonged mechanical ventilation and difficult weaning.The rHGH is a synthetic metabolic hormone which improves synthesis of protein, corrects hypoalbumenia, reverses negative nitrogen balance, improves patient nutrition, improves wound healing and promotes recovery of respiratory muscle function. When used for weaning from mechanical ventilation, rHGH reducess the duration of mechanical ventilation time, ICU admission period, incidence of VAP & ICU mortality.

NCT ID: NCT03717155 Completed - Clinical trials for Squamous Non-Small Cell Lung Cancer

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

Start date: October 30, 2018
Phase: Phase 2
Study type: Interventional

The main purpose of the study was to investigate the clinical activity and safety of avelumab in combination with cetuximab plus gemcitabine and cisplatin in participants with treatment-naïve advanced squamous non-small-cell lung cancer (NSCLC).

NCT ID: NCT03716804 Completed - Clinical trials for Antibiotic Resistant Infection

Establish the Relationship Between Shift in Prescribing Pattern and Associated Shift in Sensitivity Pattern of Causative Microbes in UTI Patients in a Closed Community

UTI
Start date: June 6, 2018
Phase: Phase 4
Study type: Interventional

To establish a relationship between changed prescribing pattern and associated shift in sensitivity trend of causative microbes in patients of uncomplicated urinary tract infection in a closed community

NCT ID: NCT03716700 Completed - Clinical trials for Primary Immunodeficiency Diseases (PID)

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Start date: September 24, 2018
Phase:
Study type: Observational

This study will provide insights on the infusion parameters, dosing, and experience of participants transitioning to CUVITRU in a real-world setting.